Table 3.

Associations of serum urate concentrations (mean ± SD) with SNP in the study population [healthy controls (n = 300) and patients with primary gout (n = 101)]. The number of study participants is provided in parentheses. p = Bonferroni test. Numbers in bold face are significant data.

SNP Identified (Allele 1/Allele 2); GeneYes, Examined Allele*No, Examined Allelep
rs11231825 (C/T); URAT1 examined allele T5.34 ± 2.23 (187)4.79 ± 2.10 (213)0.0121
rs16890979 (G/A); SLC2A9 examined allele A4.89 ± 2.02 (151)5.20 ± 2.27 (250)0.1749
rs16890979 (G/A); SLC2A9 examined allele G5.13 ± 2.21 (386)3.87 ± 0.88 (15)0.0290
rs17300741(G/A); OAT4 examined allele A5.14 ± 2.23 (296)4.71 ± 1.91 (97)0.0873
rs1165196 (T/C); NPT1 examined allele C4.96 ± 2.09 (266)5.39 ± 2.35 (132)0.0630
rs2231142 (C/A); ABCG2 examined allele A6.09 ± 2.56 (54)4.92 ± 2.08 (347)0.0003
  • * Both heterozygous and homozygous. SNP: single-nucleotide polymorphism.